Ann: Starpharma and Medicxi Partnership Petalion Therapeutics, page-43

Yes @peony-rose

Completely agree with you

This is a win-win for Starpharma........new partners with a initial investment up to AU$38
More than enough to begin clinical work on a new therapy drug

Medicxi will fund Petalion with an initial investment of up to USD $25 million (~AUD $38 million) to finance the development of a novel oncology drug candidate. Starpharma will license certain intellectual property (“IP” to Petalion as required for the research, development, manufacture and commercialisation of this potential new therapeutic and, in exchange, will receive an equity holding of 22.5% in Petalion.



Will the volume surpass 4.3 million we saw on 19/12/2023